Peterlin, Pierre, Joëlle Gaschet, Pascal Turlure, Marie-Pierre Gourin, Pierre-Yves Dumas, Sylvain Thepot, Ana Berceanu, Sophie Park, Marie-Anne Hospital, Thomas Cluzeau, Jose-Miguel Torregrosa-Diaz, Louis Drevon, Rosa Sapena, Fatiha Chermat, Lionel Ades, Sophie Dimicoli-Salazar, Maxime Jullien, Pierre Fenaux, and Patrice Chevallier. 2020. “FLT3 Ligand Kinetic Profile Predicts Response to Treatment in Patients With High-Risk Myelodysplastic Syndrome / Chronic Myelomonocytic Leukemia Receiving CPX-351: A Study from the Groupe Francophone Des Myélodysplasies”. Haematologica, September. Pavia, Italy. https://doi.org/10.3324/haematol.2024.286025.